Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Metabolism of Chrysene and Phenanthrene to Bay-Region Diol Epoxides by Rat Liver Enzymes

M. NORDQVIST, D. R. THAKKER, K. P. VYAS, H. YAGI, W. LEVIN, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology January 1981, 19 (1) 168-178;
M. NORDQVIST
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. R. THAKKER
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. P. VYAS
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. YAGI
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
W. LEVIN
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. E. RYAN
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. E. THOMAS
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. H. CONNEY
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. M. JERINA
Laboratory of Bioorganic Chemistry, National Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20205, and Department of Biochemistry and Drug Metabolism, Hoffman-La Roche Inc., Nutley, New Jersey 07110
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Liver microsomal metabolism of the weak carcinogen chrysene and the noncarcinogen phenanthrene are compared. In general, chrysene is a rather poor substrate whereas phenanthrene is a relatively good substrate for the cytochrome P-450-dependent monooxygenase system. With microsomes from 3-methylcholanthrene-treated rats, phenanthrene was metabolized at a rate of 7.6 nmoles/min/nmole of cytochrome P-450 as compared with a rate of only 1.5 with chrysene as substrate. Dihydrodiols were major metabolites for both substrates, accounting for 92%-96% of the metabolism of phenanthrene and 65%-76% of the metabolism of chrysene with microsomes from control and treated rats. The K-region 9,10-dihydrodiol is the major metabolite of phenanthrene, whereas the benzo-ring 1,2- and 3,4-dihydrodiols dominate the metabolism of chrysene from which very little K-region dihydrodiol was formed. For both hydrocarbons, microsomes from 3-methylcholanthrene-treated rats produced the (-)-[1R,2R]-dihydrodiol, which has a bay-region double bond, with ≥80% enantiomeric purity. With microsomes from phenobarbital-treated rats, the chrysene 1,2-dihydrodiol was only 10% enantiomerically pure. The (-)-[3R,4R]-dihydrodiols were the major enantiomers of phenanthrene and chrysene, whereas the (-)-[9S,1OS]-dihydriol predominated at the K-region of phenanthrene. Metabolism of the metabolically formed (-)-[1R,2R]-dihydrodiols of phenanthrene and chrysene by microsomes from 3-methylcholanthrene-treated rats resulted in the predominant formation in each case of a bay-region 1,2-diol-3,4-epoxide in which the benzylic hydroxyl group and oxirane oxygen are trans to each other (isomer-2). The respective 1,2-dihydrodiols were metabolized at the same rate as was chrysene. Thus, as had previously been observed for the metabolism of benzo[a]pyrene and benzo[a]anthracene, liver microsomal enzymes display high stereoselectivity in their formation of predominantly one of four possible stereoisomers of their respective bay-region diol epoxides. These diol epoxides from the four hydrocarbons are superimposable when their bay-regions are aligned.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 19, Issue 1
1 Jan 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Metabolism of Chrysene and Phenanthrene to Bay-Region Diol Epoxides by Rat Liver Enzymes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Metabolism of Chrysene and Phenanthrene to Bay-Region Diol Epoxides by Rat Liver Enzymes

M. NORDQVIST, D. R. THAKKER, K. P. VYAS, H. YAGI, W. LEVIN, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology January 1, 1981, 19 (1) 168-178;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Metabolism of Chrysene and Phenanthrene to Bay-Region Diol Epoxides by Rat Liver Enzymes

M. NORDQVIST, D. R. THAKKER, K. P. VYAS, H. YAGI, W. LEVIN, D. E. RYAN, P. E. THOMAS, A. H. CONNEY and D. M. JERINA
Molecular Pharmacology January 1, 1981, 19 (1) 168-178;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Antimicrobial and Antileukemic Transportan 10 Conjugates
  • Pharmacological characterization of zebrafish H1 receptor
  • Bhave and Forman
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics